GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biotest AG (XTER:BIO3) » Definitions » Float Percentage Of Total Shares Outstanding

Biotest AG (XTER:BIO3) Float Percentage Of Total Shares Outstanding : 0.00% (As of May. 21, 2025)


View and export this data going back to 1987. Start your Free Trial

What is Biotest AG Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Biotest AG's float shares is 0.00 Mil. Biotest AG's total shares outstanding is 39.57 Mil. Biotest AG's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Biotest AG's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Biotest AG's Institutional Ownership is 0.20%.

Biotest AG Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Biotest AG's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/39.57
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biotest AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biotest AG (XTER:BIO3) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
XTER:FYB XTER:HPHA STU:T9G XTER:MDG1 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270 SMMT RPRX XKRX:196170 OCSE:GMAB INSM BMRN
Traded in Other Exchanges
BTTAY:USA BIESF:USA 0N70:UK BIO3:Austria
Address
Landsteinerstrasse 5, PO Box 10 20 40, Dreieich, DEU, 63303
Website
https://www.biotest.com
Biotest AG is a supplier of biological medicines. The company produces its products from human blood plasma or manufactured by using biotechnology methods. It is engaged in the area of hematology, clinical immunology, and intensive care medicine. The company covers preclinical and clinical development of the preparations, plasma collection, production, as well as marketing and sales.
Executives
Dr. Katrin Bernöster Vice President Corp. Project + Portfolio Management
Dr. Martin Reinecke Senior Vice President plasma alliances and proteine supply
Stephan Fleck Vice President Corporate Controlling
Dr. Jörg Schüttrumpf VP Corp. Research &Development
Michael Moritz VP CC Materials & Facility Management

Biotest AG Headlines

No Headlines